サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1587416

生物学的代用皮膚の市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

Biological Skin Substitutes Market Size, Share & Trends Analysis Report By Type, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
生物学的代用皮膚の市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2024年10月31日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

生物学的代用皮膚市場の成長と動向

Grand View Research, Incの最新レポートによると、世界の生物学的代用皮膚市場規模は2030年までに5億7,908万米ドルに達し、2025～2030年にかけてCAGR 8.88％で拡大すると予測されています。

皮膚疾患の有病率の増加、慢性疾患と外傷緊急事態の発生率の上昇、潜在的なパイプライン製品とともに組織工学に関する意識の高まりは、組織ナノトランスフェクション技術の成長をもたらす主要要因の一部です。さらに、研究開発活動への政府・民間組織による投資の増加は、生物学的代用皮膚の需要を押し上げると考えられます。

バーチャルアシスタントの流行は創傷ケアプロセスのいくつかの側面に影響を及ぼしており、これには創傷ケア訪問のコンプライアンスが含まれ、バーチャルケアプラットフォームや遠隔医療の利用、創傷被覆を行う患者を支援するソーシャルメディアプラットフォームでの動画ストリーミング、自分で創傷被覆を行うアプローチの強化といった代替アプローチが引き金となっています。健康の社会的側面が創傷ケア患者のQoL（Quality of Life：生活の質）や効果にどのような影響を与えるかを理解したいという要望が高まっています。このような医療の変化の直接的な結果として、創傷ケアの継続性がいくつかの点で阻害されています。しかし、このような変化は創傷の転帰に悪影響を及ぼすだけでなく、患者訪問のためのヴァーチャルベースのアプローチを開発する原動力にもなっています。

同市場の主要企業は、製品のアップグレード、多大な協力努力の採用、買収や政府許可の検討によってポートフォリオを改善し、顧客ベースを増やして生物学的代用皮膚市場でより大きなシェアを獲得しようとしています。

生物学的代用皮膚市場レポートハイライト

  • タイプ別では、ヒトドナー組織由来製品セグメントが2024年に67.42%の最大市場シェアを占めました。
  • 用途別では、慢性創傷の有病率の増加により、慢性創傷セグメントが予測期間のCAGR 9.13%で最も速い成長が見込まれています。
  • 最終用途別では、病院セグメントが2024年の売上高シェア54.97％で生物学的代用皮膚市場を独占しています。外来患者施設セグメントは、待ち時間の短縮やより柔軟なスケジューリングオプションにより、予測期間で最も速いCAGR 8.9％が見込まれています。
  • 北米は2024年に41.25%近い最大の収益シェアを占めたが、これは同地域に主要企業が存在するためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 生物学的代用皮膚変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/付随市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
  • 生物学的代用皮膚分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 生物学的代用皮膚市場：セグメント分析、タイプ別、2018～2030年（100万米ドル）

  • 定義と範囲
  • タイプ市場シェア分析、2024年と2030年
  • 世界の生物学的代用皮膚市場、タイプ別、2018～2030年
  • 市場規模と予測と動向分析、2018～2030年

第5章 生物学的代用皮膚市場： セグメント分析、用途別、2018～2030年（100万米ドル）

  • 定義と範囲
  • 用途市場シェア分析、2024年と2030年
  • 世界の生物学的代用皮膚市場、用途別、2018～2030年
  • 市場規模と予測と動向分析、2018～2030年

第6章 生物学的代用皮膚市場：セグメント分析、最終用途別、2018～2030年（100万米ドル）

  • 定義と範囲
  • 最終用途市場シェア分析、2024年と2030年
  • 世界の生物学的代用皮膚市場、最終用途別、2018～2030年
  • 市場規模と予測と動向分析、2018～2030年

第7章 生物学的代用皮膚市場：地域別、推定・動向分析

  • 地域ダッシュボード
  • 市場規模と予測動向分析、2018～2030年：
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 市場参入企業の分類
  • 主要市場参入企業による最近の動向と影響分析
  • 企業市場シェア分析、2024年
  • 主要企業プロファイル
    • Organogenesis Inc.
    • Integra LifeSciences Corporation
    • Smith+Nephew
    • Tissue Regenix
    • MIMEDX Group, Inc.
    • Essity Aktiebolag（publ）（Essity Health & Medical）
    • Stryker
    • Vericel Corporation
    • 3M
    • BioTissue
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3 North America biological skin substitute market, by country, 2018 - 2030 (USD Million)
  • Table 4. North America biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 5. North America biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 7. U.S. biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 8. U.S. biological skin substitute, by application, 2018 - 2030 (USD Million)
  • Table 9. U.S. biological skin substitute, by end use, 2018 - 2030 (USD Million)
  • Table 10. Canada biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 11. Canada biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 12. Canada biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 13. Mexico biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 14. Mexico biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 15. Mexico biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 16. Europe biological skin substitute market, by country, 2018 - 2030 (USD Million)
  • Table 17. Europe biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 18. Europe biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 19. Europe biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 20. UK biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 21. UK biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 22. UK biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 23. Germany biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 24. Germany biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 25. Germany biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 26. France biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 27. France biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 28. France biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Italy biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 30. Italy biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 31. Italy biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 32. Spain biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 33. Spain biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 34. Spain biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 35. Norway biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 36. Norway biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 37. Norway biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 38. Sweden biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 39. Sweden biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 40. Sweden biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 41. Denmark biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 42. Denmark biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 43. Denmark biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 44. Asia Pacific biological skin substitute market, by country, 2018 - 2030 (USD Million)
  • Table 45. Asia Pacific biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 46. Asia Pacific biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 48. China biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 49. China biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 50. China biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 51. Japan biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 51. Japan biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 53. Japan biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 54. India biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 55. India biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 56. India biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 57. Australia biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 58. Australia biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 59. Australia biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 60. South Korea biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 61. South Korea biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 62. South Korea biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 63. Thailand biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 64. Thailand biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 65. Thailand biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 66. Latin America biological skin substitute market, by country, 2018 - 2030 (USD Million)
  • Table 67. Latin America biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 68. Latin America biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 69. Latin America biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 70. Brazil biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 71. Brazil biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 72. Brazil biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 73. Argentina biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 74. Argentina biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 75. Argentina biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 76. Middle East & Africa biological skin substitute market, by country, 2018 - 2030 (USD Million)
  • Table 77. Middle East & Africa biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 78. Middle East & Africa biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 79. Middle East & Africa biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 80. South Africa biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 81. South Africa biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 82. South Africa biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 83. Saudi Arabia biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 84. Saudi Arabia biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 85. Saudi Arabia biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 86. UAE biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 87. UAE biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 88. UAE biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 89. Kuwait biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 90. Kuwait biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 91. Kuwait biological skin substitute market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Disposable Syringes Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Biological Skin Substitutes Market, for Type, 2018 - 2030 (USD Million)
  • Fig. 15 Global Biological Skin Substitutes Market, for Human Donor Tissue-derived Products, 2018 - 2030 (USD Million)
  • Fig. 16 Global Biological Skin Substitutes Market, for Acellular Animal-derived Products, 2018 - 2030 (USD Million)
  • Fig. 17 Global Biological Skin Substitutes Market, for Applications, 2018 - 2030 (USD Million)
  • Fig. 18 Global Biological Skin Substitutes Market, for Acute Wounds, 2018 - 2030 (USD Million)
  • Fig. 19 Global Biological Skin Substitutes Market, for Chronic Wounds, 2018 - 2030 (USD Million)
  • Fig. 20 Global Biological Skin Substitutes Market, for End Use, 2018 - 2030 (USD Million)
  • Fig. 21 Global Biological Skin Substitutes Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 22 Global Biological Skin Substitutes Market, for Outpatient Facilities, 2018 - 2030 (USD Million)
  • Fig. 23 Global Biological Skin Substitutes Market, for Research and manufacturing, 2018 - 2030 (USD Million)
  • Fig. 24 Regional Outlook, 2023 & 2030
  • Fig. 25 North America Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 28 Mexico Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 31 UK Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 32 France Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 37 Norway Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 40 China Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 41 India Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 51 UAE Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 52 Kuwait Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-040-0

Biological Skin Substitutes Market Growth & Trends:

The global biological skin substitutes market size is expected to reach USD 579.08 million by 2030 and is expected to expand at a CAGR of 8.88% from 2025 to 2030 based on a new report by Grand View Research, Inc. The increasing prevalence of skin diseases, rising incidence of chronic diseases & trauma emergencies, and increasing consciousness regarding tissue engineering, along with potential pipeline products, are some of the major factors responsible for the growth of tissue nano transfection technology. Furthermore, increasing government and private organizations' investment in research and development activities is likely to boost the demand for biological skin substitutes.

The COVID-19 pandemic has affected several aspects of the wound care process, which includes compliance with wound care visits, triggering alternative approaches such as the use of virtual care platforms or telemedicine and streaming videos on the social media platform to assist the patients with wound dressing and empowering a do-it-yourself wound dressing approach. There is an increasing desire to understand how the social dimensions of health impact the Quality of Life (QoL) and effectiveness of wound care patients. The direct consequence of such changes in health care is the disruption of the continuity of wound care in several ways. However, these changes have negatively impacted wound outcomes but also have driven the development of a virtual-based approach for patient visits.

The key companies in the market are attempting to improve their portfolio by upgrading their products, employing significant cooperative efforts, and considering acquisitions and government permissions to increase their client base and capture a larger share of the biological skin substitutes market.

Biological Skin Substitutes Market Report Highlights:

  • Based on type, the human donor tissue-derived products segment accounted for the largest market share of 67.42% in 2024 as it allows better integration and acceptance by the patient's body
  • Based on application, the chronic wounds segment is expected to witness the fastest growth, with a CAGR of 9.13% over the forecast period due to the increasing prevalence of chronic wounds
  • Based on end-use, the hospital segment dominated the biological skin substitutes market with a revenue share of 54.97% in 2024. The outpatient facilities segment is expected to witness the fastest CAGR of 8.9% over the forecast period owing to the shorter wait times and more flexible scheduling options
  • North America accounted for the largest revenue share of nearly 41.25% in 2024 owing to the presence of major companies in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Applications
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Biological Skin Substitute Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Chronic Diseases
      • 3.2.1.2. Technological Advancements In Biological Skin Substitutes
      • 3.2.1.3. Rising Geriatric Population
      • 3.2.1.4. Increasing Surgical Procedures
      • 3.2.1.5. Growing Burn And Trauma Cases
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost Of Skin Substitute Products
      • 3.2.2.2. Regulatory Hurdles
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Growing Demand For Aesthetic Procedures
      • 3.2.3.2. Expansion In Emerging Markets
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Intense Competition
  • 3.3. Biological Skin Substitute Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Biological Skin Substitute Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2024 & 2030
  • 4.3. Global Biological Skin Substitute Market, by Type, 2018 to 2030
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.4.1. Human Donor Tissue -derived Products
      • 4.4.1.1. Human Donor Tissue-derived Products, 2018 - 2030 (USD Million)
    • 4.4.2. Acellular Animal-derived Products
      • 4.4.2.1. Acellular Animal-derived Products, 2018 - 2030 (USD Million)

Chapter 5. Biological Skin Substitute Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2024 & 2030
  • 5.3. Global Biological Skin Substitute Market, by Application, 2018 to 2030
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.4.1. Acute Wounds
      • 5.4.1.1. Acute Wounds market, 2018 - 2030 (USD Million)
    • 5.4.2. Chronic Wounds
      • 5.4.2.1. Chronic Wounds market, 2018 - 2030 (USD Million)

Chapter 6. Biological Skin Substitute Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2024 & 2030
  • 6.3. Global Biological Skin Substitute Market, by End Use, 2018 to 2030
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.4.1. Hospitals
      • 6.4.1.1. Hospitals market, 2018 - 2030 (USD Million)
    • 6.4.2. Outpatient facilities
      • 6.4.2.1. Outpatient facilities market, 2018 - 2030 (USD Million)
    • 6.4.3. Research and manufacturing
      • 6.4.3.1. Research and manufacturing market, 2018 - 2030 (USD Million)

Chapter 7. Biological Skin Substitute Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Recent Developments & Impact Analysis by Key Market Participants
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. Key Company Profiles
    • 8.4.1. Organogenesis Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Integra LifeSciences Corporation
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Smith+Nephew
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Tissue Regenix
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. MIMEDX Group, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Essity Aktiebolag (publ))( Essity Health & Medical)
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Stryker
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Vericel Corporation
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. 3M
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. BioTissue
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives